Crispr Therapeutics shares owned by Arlington Financial Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Arlington Financial Advisors
from 13F filings
Historical chart of Arlington Financial Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Arlington Financial Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Arlington Financial Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $291k | 4.3k | 68.16 |
2023-12-31 | $267k | 4.3k | 62.60 |
2023-06-30 | $237k | 4.2k | 56.14 |
2022-09-30 | $203k | 3.1k | 65.21 |
2021-12-31 | $312k | 4.1k | 75.86 |
2021-09-30 | $347k | 3.1k | 111.83 |
2021-06-30 | $496k | 3.1k | 161.93 |
2021-03-31 | $373k | 3.1k | 121.78 |
2020-12-31 | $459k | 3.0k | 153.00 |
2020-09-30 | $238k | 2.9k | 83.51 |
More positions owned by Arlington Financial Advisors
View all positions for Arlington Financial Advisors